With a decade of experience in examining the interactions between tumor cells and immune cells, my research is at the forefront of developing groundbreaking immunotherapies to improve cancer patient outcomes. Myr expertise has deepened the understanding of the complex dialogue between malignancies and the immune system. Currently, my lab is particularly concentrated on uncovering the intricate pathways within tumor specific CD8 T cells that drive their differentiation and activation. I focuss on their detailed characterization and the mechanisms by which these cells can be tuned towards effectively rejecting tumors.